“Crowdfunding has revitalized project financing. Science is next. Crowdfunding is the newest innovation in financing, all thanks to the unprecedented access to information through the Internet. Rare Genomics Institute is helping children with rare disease. PetrDish and Microryza are finding funding for research. Community laboratories are opening up to allow amateur scientists to test their [...]
IN THE SUPREME COURT OF INDIA CIVIL APPELLATE JURISDICTION CIVIL APPEAL Nos. 2706-2716 OF 2013 (ARISING OUT OF SLP(C) Nos. 20539-20549 OF 2009) NOVARTIS AG ….APPELLANT VERSUS UNION OF INDIA & OTHERS ….RESPONDENTS more…
“Every available cancer drug is susceptible to resistance, according to Mansoor Amiji, Distinguished Professor and chair of the Department of Pharmaceutical Sciences. Tumors grow more quickly than blood vessels, so these unruly masses of cells receive very little oxygen and nutrients, which means they know just how to survive under harsh conditions. They make miniature [...]
“India has revoked a patent granted to an asthma drug made by Schering Corp, later bought by U.S.-based Merck & Co (MRK.N), citing lack of invention, after Indian drugmaker Cipla Ltd (CIPL.NS) challenged an earlier decision.” “The move is the latest in a series of patent cancellations by India, where …http://in.reuters.com/article/2012/12/11/india-merck-patent-idINDEE8BA09Y20121211“
I just read Ameridose’s 483. Wow! It speaks for itself.
“A White House advisory body on Tuesday unveiled a plan to double the number of new prescription drugs that go on the market each year by more quickly approving drugs to treat high-risk patients. The President’s Council of Advisors on Science and Technology urged the Food and Drug Administration to expand its use of faster [...]keep looking »